Abstract
The decline in glomerular filtration rate (GFR) is used as outcome parameter to establish drug efficacy in clinical trials of renal disease progression. For analyzing and interpretation of trial results it is assumed that renal function declines linearly over time. However, a recent study in Afro- Americans with hypertensive nephrosclerosis documented that 42% of patients exhibit > 90% probability of non-linear GFR trajectory or prolonged period of nonprogression.
Author information
Authors and Affiliations
Corresponding author
Additional information
Parallel session 11. 14:00-15:00 diabetes, microvascular complications and cancer (nsdeg)
1 Department of Clinical Pharmacology, UMCG, Groningen, Groningen, The Netherlands, 2University of Utah, Salt Lake City UT, USA, 2 Cleveland Clinic, Cleveland, OH, USA, 3 Steno Diabetes Center, Gentofte, Denmark. E-mail: m.weldegiorgis@umcg.nl
About this article
Cite this article
Weldegiorgis, M., de Zeeuw, D., Greene, T. et al. PS11 - 1. Longitudinal eGFR trajectories in patients with type 2 diabetes. NED. TIJDSCHR. DIABET. 11, 162 (2013). https://doi.org/10.1007/s12467-013-0107-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12467-013-0107-6